Subscribe: Market Wire - Pharmaceuticals and Biotech: Drugs
Added By: Feedage Forager Feedage Grade B rated
Language: English
announces  cancer  clinical  company  diet  marketwired sep  marketwired september  marketwired  new  research  sep  september  today 
Rate this Feed
Rate this feedRate this feedRate this feedRate this feedRate this feed
Rate this feed 1 starRate this feed 2 starRate this feed 3 starRate this feed 4 starRate this feed 5 star

Comments (0)

Feed Details and Statistics Feed Statistics
Preview: Market Wire - Pharmaceuticals and Biotech: Drugs

Marketwired - Drugs

Marketwired - Drugs

Last Build Date: Fri, 30 Sep 2016 02:34:28 EDT

Copyright: Copyright: (C) Marketwired

ANGLE PLC: Research Published in Clinical Chemistry

Fri, 30 Sep 2016 02:00:00 EDT

GUILDFORD, UNITED KINGDOM--(Marketwired - Sep 30, 2016) - ANGLE plc (AIM: AGL) (OTCQX: ANPCY)

Diet Doc Offers Balanced, Doctor-Supervised Diet Plans More Effective Than the Australian Diet

Fri, 30 Sep 2016 01:00:00 EDT

BOSTON, MA--(Marketwired - September 30, 2016) - Maintaining healthy weight loss without excessive dieting is a struggle that millions of Americans face on a regular basis. Diet fads come and go seemingly every day, making it extremely challenging for individuals to find, and follow, a diet suited for their nutritional needs and physical chemistry. The Aussies' Diet, or Australian Diet, for instance, is a popular set of dietary guidelines that supposedly:

Diet Doc's Powerful New Prescription Metwell Balances Metabolism and Contributes to Fast Weight Loss

Fri, 30 Sep 2016 01:00:00 EDT

NEW YORK, NY--(Marketwired - September 30, 2016) - A well-functioning metabolism not only helps the body to burn fat more quickly, and is also key in ensuring that toxins are regularly flushed from the body. Metabolic syndrome has become more common due to poor dieting, age and a lack of activity. While many diets including paleo, keto and the Mediterranean diet can address such issues, Diet Doc -- a nationally recognized medical weight loss program has formulated a brand new prescription called, Metwell as a way to address the importance of a balanced metabolism for optimal health and weight loss and ultimate metabolic balance.

Proove Biosciences Founder & CEO, Brian Meshkin, Set to Speak at Executive Next Practices Forum on Healthcare

Thu, 29 Sep 2016 14:09:39 EDT

Renowned Expert in the Field of Precision Medicine Joins Network of Fortune 500 C-Level Executives to Discuss Impact of Genomics on Improving Outcomes in Pain

Hamilton Thorne Extends the Term of Outstanding Debentures

Thu, 29 Sep 2016 13:51:56 EDT

BEVERLY, MA and TORONTO, ON--(Marketwired - Sep 29, 2016) - Hamilton Thorne Ltd. (TSX VENTURE: HTL), a leading provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies (ART) and developmental biology research markets announced today that is has reached an agreement to amend (the "Debenture Amendments") its $300,000 unsecured subordinated debentures (the "Debentures") dated August 29, 2012 to extend the maturity date of the Debentures from October 1, 2016 to October 1, 2017. All other terms and conditions of the Debentures, as amended, were ratified and confirmed.

EAG Laboratories Appoints Duane Huggett, Ph.D., as Senior Scientific Advisor for Its Environmental Testing Group

Thu, 29 Sep 2016 12:31:00 EDT

Expert in Environmental Risk Assessment, Toxicology and Pharmacology Joins Company

Governor Brown Signs Into Law the California Cancer Clinical Trials Program

Thu, 29 Sep 2016 11:00:00 EDT

New Law Will Help Increase Patient Enrollment, Retention, and Minority Participation in Cancer Clinical Trials, Especially Among Women and Under-Represented Communities

PharmaCan More Than Doubles Acreage at In The Zone Produce Ltd.'s BC Production Campus

Thu, 29 Sep 2016 10:06:58 EDT

TORONTO, ON--(Marketwired - September 29, 2016) -

Amid 2016 Uptrend, Shares of Innovus Pharma Consolidate on Technical Support -

Thu, 29 Sep 2016 10:04:29 EDT

REDONDO BEACH, CA--(Marketwired - Sep 29, 2016) -, a leading financial news and information portal offering free real time public filing alerts, recently published an article analyzing Innovus Pharmaceuticals' (OTCQB: INNV) stock chart from a technical perspective, along with a discussion of the company's fundamentals.

Clasado BioSciences to Showcase Bimuno(R) for First Time at SupplySide West

Thu, 29 Sep 2016 10:02:00 EDT

Leading Biotech Company Launches Patent Protected Galacto-Oligosaccharide Bimuno(R) (B-GOS(R)) at Prominent Industry Trade Show

John Brower Jr. Foundation Hosts Second Annual Walk for Heroin Addiction Awareness and Prevention

Thu, 29 Sep 2016 09:00:00 EDT

On Saturday October 8th the John Brower Jr. Foundation Will Host Their Second Annual Walk at Jones Beach to Raise Awareness to the Opiate Epidemic on Long Island

Endonovo at the Intersection of Stem Cells and Biologics for Next Generation Therapeutics -

Thu, 29 Sep 2016 08:58:46 EDT

REDONDO BEACH, CA--(Marketwired - Sep 29, 2016) -, a leading financial news and information portal offering free real time public filing alerts, recently published an article covering the unique technology that Endonovo Therapeutics (OTCQB: ENDV) is applying in the development of biologics and stem cells.

iBio Proprietary Technology Advances Neonatal Respiratory Distress Syndrome Drug Development for South African Biotech Company AzarGen Biotechnologies (Pty) Ltd

Thu, 29 Sep 2016 08:30:00 EDT

NEW YORK, NY--(Marketwired - Sep 29, 2016) - iBio, Inc. (NYSE MKT: IBIO), a leading provider of plant-based biotechnology for developing and manufacturing biological products announced the successful application of its proprietary technologies to achieve the first milestone in its commercial development agreement with AzarGen Biotechnologies (Pty) Ltd (AzarGen) of South Africa for the development and manufacture of an improved surfactant protein for the treatment of neonatal respiratory distress syndrome (RDS).

Critical Outcome Technologies Reports Fiscal 2017 First Quarter Financial and Operating Results

Thu, 29 Sep 2016 08:30:00 EDT

LONDON, ON and BOSTON, MA--(Marketwired - September 29, 2016) - Critical Outcome Technologies Inc. (TSX VENTURE: COT) (OTCQB: COTQF) ("COTI" or the "Company") reported its financial and operating results today for the three-month period ended July 31, 2016. Major highlights for the quarter included:

Aequus Obtains Ontario Provincial Listing for Vistitan(TM)

Thu, 29 Sep 2016 08:00:00 EDT

VANCOUVER, BC--(Marketwired - September 29, 2016) - Aequus Pharmaceuticals Inc. (TSX VENTURE: AQS) (OTCQB: AQSZF) ("Aequus" or the "Company"), a specialty pharmaceutical company with a focus on developing, advancing and promoting differentiated products, announced today that it has successfully obtained provincial formulary coverage from the Ontario Drug Benefit Program for PrVistitanT (bimatoprost 0.03% w/v, ophthalmic solution). According to IMS data, over 80% of Ontario's glaucoma patient population rely on public medication coverage, who will now have improved access to this product.

Abeona Therapeutics to Present at Cell Gene Meeting on the Mesa

Thu, 29 Sep 2016 07:03:00 EDT

Company CEO to Present on October 5th at 11:15 am PT

RNA-Seq in Colorectal Cancer Defines Neoplastic and Stromal Features Impacting Future Treatments, New Webinar Hosted by Xtalks

Thu, 29 Sep 2016 07:00:00 EDT

TORONTO, ON--(Marketwired - September 29, 2016) - In this webinar, industry expert Dr. Enzo Medico, Associate Professor at the University of Torino, School of Medicine, Candiolo Cancer Institute will outline research studies that have been performed to exploit global transcriptional profiling of colorectal cancer samples.

Vernalis PLC Announces Results Announcement for the 12 Months Ended 30 June 2016

Thu, 29 Sep 2016 02:00:00 EDT

WINNERSH, UNITED KINGDOM--(Marketwired - Sep 29, 2016) - Vernalis PLC (LSE: VER) (OTC PINK: VNLPY)

Tiziana Life Sciences PLC Announces Interim Results for the Six Months Ended 30 June 2016

Thu, 29 Sep 2016 02:00:00 EDT

LONDON, UNTIED KINGDOM--(Marketwired - Sep 29, 2016) - Tiziana Life Sciences plc (AIM: TILS)

Diet Doc Introduces New Powerful Appetite Suppressant for Those Consuming Low-Calorie Diets

Thu, 29 Sep 2016 01:00:00 EDT

LITTLE ROCK, AR--(Marketwired - September 29, 2016) - The Cabbage Soup diet is a 7-day meal plan that consists primarily of cabbage soup but also fruit, vegetables and the incorporation of meat and rice toward the end of the week. It is considered a low-fat, high-fiber diet that should only be followed on a temporary basis in order to lose weight quickly. Supporters of the diet claim that the cabbage soup diet has helped them to lose up to 10 pounds within one week, however experts say that the diet's lack or protein as well as other fundamental nutrients can easily lead to the regaining of all weight lost after the diet has concluded.

Avita Medical Signs Exclusive Distributor Deal in Iran

Wed, 28 Sep 2016 23:42:19 EDT

Dedicated ReNovaCell(TM) Clinic to Open in Tehran

SMP Pharmacy Solutions Receives Eighth Inc. 5000 Recognition

Wed, 28 Sep 2016 15:07:37 EDT

Miami-Based Specialty Pharmacy Listed Among Top 20% of America's Fastest-Growing Private Companies

How Far Will You Go to Defeat Type 1 Diabetes

Wed, 28 Sep 2016 15:00:00 EDT

Canadians Ride Up to the Challenge; JDRF Revolution Ride

Medtronic, Phillips Healthcare Lead High Demand Billion Dollar U.S. Patient Monitoring Market

Wed, 28 Sep 2016 13:17:54 EDT

The U.S. Patient Monitoring Market Is Expected to Grow Over the Next Several Years to Reach Over $6 Billion by 2023

NCCN Congress to Explore Complex Issues in Treating Hematologic Malignancies

Wed, 28 Sep 2016 13:15:00 EDT

The NCCN 11th Annual Congress: Hematologic Malignancies(TM) Returns to New York City September 30 - October 1, 2016; Registration Is Still Open at

Commence Bio to Present at 2016 Cell & Gene Meeting on the Mesa

Wed, 28 Sep 2016 12:37:22 EDT

SPARKS, MD--(Marketwired - September 28, 2016) - Commence Bio, Inc., a biotechnology company focused on developing breakthrough immunotherapies using its proprietary STaRTT platform, announced today that Thomas Isett, CEO and Co-Founder, will present a company overview at the 2016 Cell & Gene Meeting on the Mesa [CGMOM]. Scheduled for October 5, at 2:45 PM (PDT), the presentation will highlight developments with the application of STaRT to create MSC1 and MSC2 cellular therapies for immuno-oncology and immune-mediated inflammatory diseases.

Neptune publiera ses résultats du deuxième trimestre pour la période intermédiaire terminée le 31 août 2016

Wed, 28 Sep 2016 10:51:09 EDT

LAVAL, QUÉBEC--(Marketwired - 28 sept. 2016) - Neptune Technologies & Bioressources inc. (NASDAQ:NEPT)(TSX:NTB) (« Neptune » ou « la Société »), annonce qu'elle tiendra une conférence téléphonique le 12 octobre 2016 à 17h00, (heure normale de l'est) afin de commenter les résultats financiers du deuxième trimestre pour la période intermédiaire terminée le 31 août 2016.

Neptune to Hold Conference Call to Discuss Second Quarter Results for the Period Ended August 31, 2016

Wed, 28 Sep 2016 10:50:32 EDT

LAVAL, QUÉBEC--(Marketwired - Sept. 28, 2016) - Neptune Technologies & Bioressources Inc. ("Neptune" or the "Company") (NASDAQ:NEPT)(TSX:NTB), announces that it will be holding a conference call on October 12, 2016 at 5:00 PM (EST) to discuss its second quarter results for the period ended August 31, 2016.

Health Advance Signs Letter of Intent to Acquire Hantian Labs

Wed, 28 Sep 2016 10:48:43 EDT

LAS VEGAS, NV--(Marketwired - Sep 28, 2016) - Health Advance Inc. (OTC PINK: HADV) (Hereinafter referred to as "the Company" or "HADV") is pleased to announce it has entered into a non-binding Letter of Intent to acquire 100% interest in Hantian Labs Limited, a private UK corporation (Hereinafter referred to as "Hantian"). The acquisition is subject to due diligence by both parties, and the negotiation and execution of a definitive agreement. The agreement will be subject to certain conditions including HADV issuing 15,000,000 shares of the Company in exchange for all the issued and outstanding shares in Hantian.

Cannabis Science Launches New Medicinal Product Line in Legal Dispensaries Within the State of California for Self-Medicating Patients

Wed, 28 Sep 2016 10:40:45 EDT

IRVINE, CA--(Marketwired - Sep 28, 2016) -  Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabis-based medicines, is pleased to announce Cannabis Science launches new medicinal product lines for self-medicating patients via legal dispensaries and delivery within the State of California. The new CBIS medicinal product lines are being released based on patient usage data and general public opinion. The Company works with leading experts in drug development, medicinal characterization, and clinical research to develop, produce, and commercialize target medicines for target ailments. These new medicinal products will be centerpieces for its new medicinal studies targeting its initial critical ailment list.

Medrio Rocks the House Down With Live Software Demonstrations at SCDM 2016

Wed, 28 Sep 2016 10:00:00 EDT

SAN FRANCISCO, CA--(Marketwired - September 28, 2016) - Medrio, a Software as a Service (SaaS) company providing electronic data capture (EDC) services to clinical trials, brought its Medrio Rocks World Tour to the Society for Clinical Data Management (SCDM) conference in San Diego from September 11 - 13. Hundreds of clinical data management professionals filled the Sheraton San Diego Hotel & Marina, including over 200 Medrio fans, who rushed to the front row at booth 201 to rock out to the company's chart-topping EDC.

New Features, Additional Keynote Speakers Will Round out 11th Annual Cardiometabolic Health Congress

Wed, 28 Sep 2016 09:39:41 EDT

BOSTON, MA--(Marketwired - September 28, 2016) - Continuing its dedication to translating late-breaking clinical research on cardiometabolic risk reduction into practical and targeted education, the Cardiometabolic Health Congress will hold its 11th Annual CMHC from October 5-8, 2016 at the Sheraton in Boston, MA.

AssistRx Shares Insight Into Maximizing Workflow Efficiency at the 7th Hub and SPP Model Optimization Conference

Wed, 28 Sep 2016 09:01:00 EDT

Company Calls on the Specialty Pharmaceutical Industry to Leverage Technology and Improve the Patient Experience

The Alliance for Regenerative Medicine Announces Fourth Annual 2016 European Advanced Therapies Investor Day

Wed, 28 Sep 2016 09:00:00 EDT

WASHINGTON, DC--(Marketwired - Sep 28, 2016) - The Alliance for Regenerative Medicine (ARM), the international advocacy organization representing the cell and gene therapy and broader regenerative medicine sector, announced its annual European Advanced Therapies Investor Day will be held November 3, 2016 in London.

Defining Patient-Centricity Success Metrics & Demonstrating Initiative Value

Wed, 28 Sep 2016 08:31:00 EDT

20% of Pharmaceutical Companies Struggle Due to Increased Focus on Consumer Experience

GrowPros Announces Name Change to Tetra Bio-Pharma Inc., the Closing of A Non-Brokered Private Placement, and Extends Warrants

Wed, 28 Sep 2016 08:30:00 EDT

OTTAWA, ONTARIO--(Marketwired - Sept. 28, 2016) - GrowPros Cannabis Ventures Inc. ("GrowPros" or "the Company") (CSE:GCI) announces that the Company has changed its name to Tetra Bio-Pharma Inc. and has a new stock symbol CSE:TBP effective immediately.

The American Green Machine (V.3) Coming to Market

Wed, 28 Sep 2016 08:00:00 EDT

TEMPE, AZ--(Marketwired - Sep 28, 2016) - American Green, Inc. (OTC PINK: ERBB) is excited to announce today that the new model of the American Green Machine is now available for purchase. After nearly a year of vendor feedback and market analysis, it became clear that the changes made were necessary to insure the successful rollout of the company's new-wave vending product. One of the major improvements in the new machine version is that every unit will be able to sell ANY product -- from the most regulated to virtually any specialty item. This makes Version 3 of the American Green Machine "product-agnostic." The company has also been able to work with the top level biometric companies in the world to ensure that any purchase fulfilled through the system would be accepted by the world's top banks and governments.

Corbus Announces Data on Effects of Resunab (JBT-101) in a Clinical Research Model of Resolution of Inflammation

Wed, 28 Sep 2016 07:30:00 EDT

Data Presented at the 6th European Workshop on Lipid Mediators, Wednesday, September 28 at 11:40 AM CET / 5:40 AM EST

mCig, Inc. CEO to Retire 50 Million Underlying Common Shares of Company Stock to the Company Treasury

Wed, 28 Sep 2016 07:00:00 EDT

HENDERSON, NV--(Marketwired - Sep 28, 2016) - mCig, Inc. (OTCQB: MCIG), a diversified company servicing the legal cannabis, hemp, and CBD markets, announced today its Chairman and CEO, Paul Rosenberg, is pleased to announce he has voluntarily returned 5 million Series A Preferred shares, representing 50 million underlying common stock to the company treasury. The process will be completed by September 30th, 2016.

Tissue Collection Standards Determine the Future of Precision Medicine, New Webinar Hosted by Xtalks

Wed, 28 Sep 2016 07:00:00 EDT

TORONTO, ON--(Marketwired - September 28, 2016) - Join industry expert Dr. Hartmut Juhl, Professor, Founder and CEO of Indivumed GmbH and IndivuTest GmbH (Hamburg), as he discusses how tissue collections standards will play a role in the future of precision medicine. There will be two live broadcasts on Tuesday, October 18, 2016 at 9am EDT (2pm BST/UK) and 1pm EDT.

Freedom Leaf, Inc. (OTC PINK: FRLF) Hosted the Students for Sensible Drug Policy's Sensible Soiree in Nevada

Wed, 28 Sep 2016 06:30:00 EDT

LAS VEGAS, NV--(Marketwired - Sep 28, 2016) - On Monday, September 19, 2016 in Las Vegas, Nevada, Freedom Leaf, Inc. (OTC PINK: FRLF) hosted the Students for Sensible Drug Policy's Sensible Soirée. It was an effort to support Students for Sensible Drug Policy's (SSDP) movement to provide meaningful resources to Nevada's youth. SSDP mobilizes and empowers young people to influence the political process and advocate for more sensible drug policies in order to achieve a safer and more just future. SSDP fights to untangle dangerous and counterproductive Drug War policies, particularly those that directly harm students and youth.

Medivation Highlights New Data From Differentiated Oncology Portfolio at ESMO 2016

Wed, 28 Sep 2016 06:00:00 EDT

SAN FRANCISCO, CA--(Marketwired - September 28, 2016) - Medivation, Inc. (NASDAQ: MDVN) today announced that new data from Company-sponsored and investigator-initiated clinical trials will be presented at the European Society for Medical Oncology (ESMO) 2016 Congress, being held October 7-11, in Copenhagen. Presentations include a pilot study of the company's investigational PARP inhibitor talazoparib in patients with BRCA-mutated breast cancer, and analyses of enzalutamide in the advanced prostate cancer setting, representing research advances in serious diseases for which there are limited options.

Dr. Rao of Diet Doc Believes That Even Natural Diet Pills Should Be Used Under Medical Supervision

Wed, 28 Sep 2016 01:00:00 EDT

HATTIESBURG, MS--(Marketwired - September 28, 2016) - With the evolution of increasingly sedentary lifestyles and tons of conflicting information regarding which diets are best for weight loss, there has been a recent and steadily growing demand for diet pills and supplements. A popular weight loss pill that exist on the market today, is the Exo Slim Garcinia Cambogia diet pill. It is reported to offer such benefits as, an increased metabolic rate, appetite control, fat blocking, improved digestion and ultimately, weight loss. Given the prevalence of the obesity epidemic and its effects on the population, losing excess fat can help to prevent or reduce many chronic diseases associated with high body fat.

Redi-Data to Offer New Healthcare Professional Microtargeting Capabilities with ICD-9/ICD-10 Data

Tue, 27 Sep 2016 15:37:53 EDT

FAIRFIELD, NJ--(Marketwired - September 27, 2016) - Redi-Data, Inc., a leading provider of healthcare professional, consumer and business postal emails lists, announced today that it will offer the ability to microtarget healthcare practitioners via insurance claims data. Clients will soon be able to define target audiences utilizing ICD-9, ICD-10, CPT and HCPCS information. ICD-10-CM is the diagnosis code set that will be replacing ICD-9 volumes 1 and 2.

Whistler Medical Marijuana Corporation (WMMC), a Certified Organic Licensed Producer of Medical Cannabis, Today Announced the Release of Canada's First High Cannabigerol (CBG) Cannabis Oil

Tue, 27 Sep 2016 13:49:56 EDT

WHISTLER, BC--(Marketwired - September 27, 2016) - The release follows two years of research identifying the best medical phenotypes from the diverse seed bank at WMMC. The process identified a unique phenotype containing significant amounts of both THC and CBG at maturity which now forms the starting material for their High CBG oil.

Premier Biomedical Pain Management Solutions Announces Shipment of Initial Samples of Opioid-Free, 50-State Legal, CBD-Based Pain-Relieving Topical Patch

Tue, 27 Sep 2016 10:00:00 EDT

EL PASO, TX--(Marketwired - Sep 27, 2016) -  Premier Biomedical, Inc. (OTCQB: BIEI) announced today their newly created joint venture company, Premier Biomedical Pain Management Solutions, LLC (PBPMS) has manufactured and shipped initial design sample pain relieving topical patches for distribution to select VA hospital patients, military personnel, doctors, and professional sports figures. These patent-pending, opioid- and narcotic-free all-natural-ingredient topical pain relief patches consist of a proprietary mechanism for extended delivery of their cannabis-based medical CBD pain relieving compound, which is legal in all 50 states.

Nutritional High Provides an Update on its Colorado Project

Tue, 27 Sep 2016 09:47:10 EDT

TORONTO, ONTARIO--(Marketwired - Sept. 27, 2016) - Nutritional High International Inc. (the "Company" or "Nutritional High") (CSE:EAT)(OTCQB:SPLIF)(FRANKFURT:2NU), is pleased to report key developments at its project in West Pueblo, Colorado.

Johnson & Wales University Announces The Food Innovation Nexus: a Venture Towards Therapeutic Breakthroughs in Healthy Food and Medicine

Tue, 27 Sep 2016 09:06:00 EDT

PROVIDENCE, RI--(Marketwired - September 27, 2016) - Johnson & Wales University (JWU), a world-renowned culinary educator, is no stranger to food innovation. Today it is announcing its newest venture to spur therapeutic breakthroughs at the intersection of healthy food and medicine: The Food Innovation Nexus (FIX).

AssistRx Announces Integration With Leading E-Prescribing Service, NewCrop

Tue, 27 Sep 2016 09:01:00 EDT

Market's Most Efficient Specialty Medication Workflow Solution Integrates With the E-Prescribing Service to Improve Capabilities for EHRs and Healthcare Organizations

Itonis, Inc. Announces Its Emesyl Anti-Nausea Product is Again Available for Purchase via

Tue, 27 Sep 2016 09:00:00 EDT

LAGUNA HILLS, CA--(Marketwired - September 27, 2016) - Itonis, Inc. (OTC PINK: ITNS) is pleased to announce that its Emesyl® anti-nausea homeopathic product is again available for purchase via

CV Sciences, Inc. Issues Letter to Shareholders

Tue, 27 Sep 2016 08:45:00 EDT

LAS VEGAS, NV--(Marketwired - September 27, 2016) - CV Sciences, Inc. (OTCBB: CVSI) (the "Company", "CV Sciences", "our" or "we"), issued a letter today to its shareholders discussing recent events and highlights.

BioNap Consulting's Jason Napodano Issues an Update on BriaCell Therapeutics Corp.

Tue, 27 Sep 2016 08:30:00 EDT

BERKELEY, CA and VANCOUVER, BC--(Marketwired - September 27, 2016) - BioNap Consulting, Inc.'s Senior Equity Analyst, Jason Napodano, CFA, issued an update outlining the meaningful progress of BriaCell Therapeutics Corp. (TSX VENTURE: BCT) (OTCQB: BCTXF) or BriaCell towards initiation of Phase I/IIa clinical testing of BriaVaxT, BriaCell's proprietary allogeneic whole tumor cell vaccine, in late-stage breast cancer patients in the fourth quarter of 2016.

American Cannabis Company Inc. Features SoHum Living Soil(TM) at Canadian Industry Event and Establishes 8 New Retail Accounts

Tue, 27 Sep 2016 08:30:00 EDT

DENVER, CO--(Marketwired - Sep 27, 2016) - American Cannabis Company, Inc. (OTCQB: AMMJ) (the "Company"), a full-service business-to-business consulting solutions provider, product manufacturer and seller of ancillary products to the cannabis industry, today announced that it was in attendance at a Canadian industry event featuring its SoHum Living SoilsT product and that it successfully established eight new retail sales accounts for the SoHumT brand. ACC expects to begin filling these retail pre-orders in the spring of 2017.

North Springs Resources Corp. Announces the Unveiling of Major Business Announcement to Shareholders Before Oct 1st 2016

Tue, 27 Sep 2016 08:30:00 EDT

RIVERVIEW, FL--(Marketwired - Sep 27, 2016) - North Springs Resources Corp. (OTC PINK: NSRS) is pleased to announce that the Company has worked closely with the Company's strategic partner and plans to issue an update to shareholders on or before Oct 1st 2016 regarding a contractual agreement that is expected to have a substantial and beneficial impact on the Company and its shareholders.

Top 5 Factors Pharma Companies Consider When Compensating Clinical Investigators

Tue, 27 Sep 2016 08:19:00 EDT

RESEARCH TRIANGLE PARK, NC--(Marketwired - September 27, 2016) - The most important factor to determining clinical investigator compensation is the physician's therapeutic specialty, according to a report published by pharmaceutical competitive intelligence firm Cutting Edge Information.

Reflect Scientific's Cryometrix Ultra Low Temperature Freezers Go International

Tue, 27 Sep 2016 08:00:00 EDT

OREM, UT--(Marketwired - September 27, 2016) - Reflect Scientific, Inc. (OTCQB: RSCF), a provider of diverse products and services for the biotechnology, pharmaceutical and transportation industries announced the first international order has been received from a major research institute in Bangkok, Thailand.

A prominent research institute in Bangkok, Thailand has placed an order for the Cryometrix T-90 ULT freezer for sample storage. In a correspondence sent to Reflect Scientific Inc. the institute wrote, "Currently, our organization has more than 100 units of -86C electrical freezers and our Director would like us to reduce electrical consumption and eliminate the use of CFC's. Your products were brought to our attention." The T-90 is a patented ultra low temperature freezer that utilizes liquid nitrogen as the coolant and uses very few moving parts resulting in a very environmentally friendly, reliable product. Mr. Boyce, CEO of Reflect Scientific Inc., commented, "I am excited to see that the excellent reputation of our Cryometrix freezers has spread to international customers. This opens up a large potential market for our freezer product line."

Adgero Biopharmaceuticals to Present at the Fifth Annual OktoberINVESTfest, US - Bavaria, Germany Investors Conference in New York

Tue, 27 Sep 2016 07:30:00 EDT

German, US Business Leaders and Investors to Convene September 28th at NY Academy of Sciences

Blood Cancer Drugs Leading Growth in Global Hematology Market, Reports BCC Research

Tue, 27 Sep 2016 05:00:00 EDT

WELLESLEY, MA--(Marketwired - September 27, 2016) - Incidence and mortality rates for most cancers are increasing in emerging countries, mostly due to the adoption of unhealthy Western lifestyles such as smoking, physical inactivity, and diet. BCC Research reveals in its new report that the hematological cancer drug sector is leading growth in the global market for hematology drugs and diagnostics.

Diet Doc Releases Doctor-Supervised Genetic Testing for Rapid Weight Loss Without 'Military Diet'

Tue, 27 Sep 2016 01:00:00 EDT

MERIDIAN, MS--(Marketwired - September 27, 2016) - More than sixty percent of Americans are overweight or obese, battling excessive hunger between meals and attempting to ignore uncontrollable cravings for unhealthy food. Seemingly unexplainable emotional eating due to everyday stress is also quite common and the majority of overweight people are unable to maintain weight loss for more than a year.

The LAM Foundation Hosts Largest Rare Lung Disease Conference of Its Kind in Cincinnati

Mon, 26 Sep 2016 20:29:52 EDT

New $3.6 Million NIH Grant for MILED Trial and New Clinical Guidelines for LAM Introduced at the Joint Meeting of Scientists and Patients

Pieris Pharmaceuticals Presents Positive Data for Its Lead Bispecific Drug Candidate, PRS-343, at the 2016 CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference

Mon, 26 Sep 2016 17:15:00 EDT

Novel 4-1BB/HER2 Bispecific Demonstrates Differentiation Over Conventional 4-1BB mAb and HER2 mAb Approaches

Biodel Announces 2016 Annual Meeting of Stockholders Set for October 24, 2016; Outlines Plan to Regain Compliance With Nasdaq Listing Requirements

Mon, 26 Sep 2016 16:30:00 EDT

DANBURY, CT--(Marketwired - September 26, 2016) - Biodel Inc. (NASDAQ: BIOD) today announced that its 2016 annual meeting of stockholders has been set for October 24, 2016. At that meeting, stockholders will vote on, among other things, matters necessary to complete Biodel's planned transaction with Albireo Limited pursuant to a previously announced share exchange agreement, including the issuance of shares of Biodel's common stock in the transaction and a proposed reverse stock split of Biodel's common stock at a ratio of 1-for-30 shares.

Ogilvy CommonHealth Worldwide's Ritesh Patel to Deliver a Keynote Address at the Technology for Marketing 2016 Conference

Mon, 26 Sep 2016 13:51:52 EDT

PARSIPPANY, NJ--(Marketwired - Sep 26, 2016) - Ogilvy CommonHealth Worldwide (, the health behavior change specialists of Ogilvy & Mather (, and a WPP company (NASDAQ: WPPGY) (, today announced Ritesh Patel, EVP, chief digital officer, has been selected as a keynote speaker at the 2016 Technology for Marketing event taking place on September 28 and 29 in Olympia London.

NCCN Publishes New Clinical Practice Guidelines for Myeloproliferative Neoplasms

Mon, 26 Sep 2016 12:03:22 EDT

New NCCN Guidelines for Myeloproliferative Neoplasms Focus on the Treatment of Myelofibrosis, a Rare Bone Marrow Cancer; the New Recommendations Are the Most Comprehensive Treatment Guidance Available to U.S. Clinicians Today

MasterControl Provides Industry Insight on Leveraging Big Data in Post-Market Surveillance at Medical Product and Outsourcing's 2016 Summit

Mon, 26 Sep 2016 11:57:37 EDT

AUSTIN, TX--(Marketwired - Sep 26, 2016) -  MasterControl, a leading global provider of enterprise quality management systems (EQMS) and quality and compliance consulting services, will offer valuable information for the medical device industry at Medical Product and Outsourcing's Summit Oct. 5-6 in Austin, Texas.

Easton Pharmaceuticals Announces Receiving Mexican Regulatory Approval for VagiSan (VS-Sense) Diagnostic Device, in Support of On-Going Exclusive Distribution Negotiations With Multi-National Pharmaceutical Companies for Major Latin American Markets

Mon, 26 Sep 2016 10:45:42 EDT

TORONTO, ON--(Marketwired - Sep 26, 2016) - Easton Pharmaceuticals Inc. (OTC PINK: EAPH) announces COFEPRIS (Mexican Ministry of Health) has granted Marketing Authorization for VagiSan (also known as VS-Sense) diagnostic test, supporting on-going exclusive partnership negotiations for Mexico and other Latin American markets with several multinational pharmaceutical companies.

OncBioMune CEO Dr. Jonathan Head to Present Abstract on Prostate Cancer Vaccine at Second CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference: Translating Science Into Survival

Mon, 26 Sep 2016 10:41:46 EDT

BATON ROUGE, LA--(Marketwired - September 26, 2016) - OncBioMune Pharmaceuticals, Inc. (OTCQB: OBMP) ("OncBioMune" or the "Company"), a clinical stage biopharmaceutical company engaged in the development of novel cancer products and a proprietary vaccine technology, announces that OncBioMune Chief Executive Officer Dr. Jonathan Head will be making an abstract poster presentation today at the Second CRI-CIMT-EATI-AACR International Cancer Immunotherapy Conference: Translating Science into Survival. The conference is being hosted at the Sheraton New York Times Square Hotel in New York, New York from September 25-28.

Mr. Raymond C. Dabney, CBIS CEO, Accepts Invitation to Speak at Harvard Medical School

Mon, 26 Sep 2016 10:18:41 EDT

WASHINGTON, DC--(Marketwired - Sep 26, 2016) - Cannabis Science, Inc. (OTC PINK: CBIS), a U.S. company specializing in the development of cannabis-based medicines, announces that its President, Chief Executive Officer, and Co-Founder, Mr. Raymond C. Dabney, has accepted an invitation to speak at Harvard Medical School this November. Mr. Dabney will speak at the Dana Farber/Harvard Cancer Center (DF/HCC), one of the largest cancer research centers in the world with more than 1,100 cancer researchers and over $600 million in cancer research funding. He will discuss CBIS' drug development initiatives targeting a variety of cancers, within the context of a number of other disorders, such as autism spectrum disorders, asthma, as well as pain management.

Sermonix Pharmaceuticals' Exploratory Analysis on Orgasm Frequency With SERMs Is Named Featured Poster for 2016 North American Menopause Society Annual Meeting

Mon, 26 Sep 2016 09:55:00 EDT

Sermonix Also to Present Poster on Physicians' Perceptions of SERMs in Menopausal Health

Player's Network CEO Third Quarter Shareholder Update

Mon, 26 Sep 2016 09:46:47 EDT

Company Secures $2.5 Million in Funding, Reduces Its Debt, Begin Construction on Its MME Facilities, Comcast Lawsuit Update and More

TraceLink to Discuss Global Serialisation Strategies at CPhI Worldwide

Mon, 26 Sep 2016 09:00:00 EDT

NORTH READING, MA--(Marketwired - Sep 26, 2016) -  TraceLink Inc., the World's Largest Track and Trace Network for connecting the life sciences supply chain and eliminating counterfeit prescription drugs from the global marketplace, will be addressing delegates at CPhI Worldwide, the annual pharmaceutical congress taking place October 4 - 6, in Barcelona, Spain. TraceLink will be partnering with its customer, Sharp Packaging Services, to display its proven Life Sciences Cloud solution in the Sharp CPhI booth in Hall 3, Stand L56.

Aldeyra Therapeutics Provides Update on Late-Stage Clinical Trials at 2016 Research and Development Day

Mon, 26 Sep 2016 08:30:00 EDT

LEXINGTON, MA--(Marketwired - Sep 26, 2016) - Aldeyra Therapeutics, Inc. (NASDAQ: ALDX)

Pacific Therapeutics Receives Revenue Update from Tower Three

Mon, 26 Sep 2016 08:30:00 EDT

VANCOUVER, BRITISH COLUMBIA--(Marketwired - Sept. 26, 2016) - Pacific Therapeutics Ltd. (CSE:PT)(OTC PINK:PCFTF)(Frankfurt:1P3) (the "Company") announces that it has received a corporate update regarding its proposed transaction (the "Transaction") with Tower Three SAS (the "T3"), a South American telecommunications infrastructure developer. T3 has received its first rental payment from a major telecom provider (the "Anchor Tenant") for use of three towers out of the first ten tower development. The Company has received information that T3's fourth and fifth towers are expected to be completed and connected within the next several weeks. In addition, the remaining five towers are in the late stages of social development consultation. The Company was also informed that T3 has been awarded ten additional search rings (Desired Coordinates) from a cellular carrier, for areas in which cellular coverage and capacity is weak or lacking. Alex Ochoa CEO of T3, states: "This is a monumental milestone for Tower Three as we have now become a reoccurring revenue generating company with immediate cash returns starting within 45 days of every tower construction completion."

PhytoPain Pharma Provides USA Regulatory Update for Its Cannabis Inhalation Product PPP001

Mon, 26 Sep 2016 08:30:00 EDT

OTTAWA, ONTARIO--(Marketwired - Sept. 26, 2016) - PhytoPain Pharma ("PPP"), a subsidiary of GrowPros Cannabis Ventures Inc. ("GrowPros" or the "Company" or "GCI") (CSE:GCI), a pharmaceutical company focused on developing and commercializing therapeutic cannabis-based products for the treatment of pain and other medical conditions, received an Acknowledgement Letter from the U.S. Food and Drug Administration ("FDA") after submitting a Request for Designation ("RFD"). PPP had filed a RFD for PPP001 to be classified as a drug and assigned to the Center for Drug Evaluation and Research ("CDER"). The RFD enables the FDA to determine the product type and appropriate lead center. If the FDA has not issued a designation letter within 60 calendar days of the filing of the RFD, PPP's recommendation will become the designated classification and assignment.

DiamiR Provides Update on Its Patent Portfolio, Launches New Website

Mon, 26 Sep 2016 08:02:00 EDT

MONMOUTH JUNCTION, NJ--(Marketwired - September 26, 2016) - DiamiR, LLC, a developer of innovative minimally invasive diagnostic tests for neurodegenerative and other diseases, reported today that the following new patents have been issued or allowed between April and September 2016:

"Methods of using small RNA from bodily fluids for diagnosis and monitoring of neurodegenerative diseases" in Europe (issued in the United States in February 2014);

ORYZON Closes EUR 5.3 Million (6 M USD) in additional Debt Financing

Mon, 26 Sep 2016 08:00:00 EDT

With These Funds the Company Completes Its Global Funding of EUR 32 Million (36 Million USD)

Abeona Therapeutics Enrolls First Patient in Phase 2 for EB-101 Gene Therapy Clinical Trial for Epidermolysis Bullosa

Mon, 26 Sep 2016 07:03:00 EDT

NEW YORK, NY and CLEVELAND, OH--(Marketwired - September 26, 2016) - Abeona Therapeutics Inc. (NASDAQ: ABEO)

  • Phase 1 clinical trial in five patients demonstrated EB-101 (gene corrected skin grafts) was well tolerated and demonstrated promising clinical efficacy in patients for the treatment of recessive dystrophic epidermolysis bullosa (RDEB)
  • Significant improvements in wound healing and gene expression observed up to 12 months post-treatment

Abeona Therapeutics Inc. (NASDAQ: ABEO) a clinical-stage biopharmaceutical company focused on delivering gene therapies for life-threatening rare diseases, announced that the first patient was enrolled in the Phase 2 portion of the clinical trial for EB-101 (gene-corrected skin grafts). EB-101 is the Company's lead gene therapy program for patients suffering with recessive dystrophic epidermolysis bullosa (RDEB), a severe form of epidermolysis bullosa (EB).

Upcoming Webinar to Examine Market Access Hurdles for Cell and Gene Therapies

Mon, 26 Sep 2016 07:00:00 EDT

TORONTO, ON--(Marketwired - September 26, 2016) - The presentation will focus on managing evidence including market access and reimbursement challenges around cell and gene therapies to enhance market adoption.

If Canada Adopts New Zealand's Prescription Drug Policies There Will Be Fewer Treatment Options and Poorer Health Outcomes for Patients: Canadian Health Policy Institute (CHPI) Study

Mon, 26 Sep 2016 06:00:00 EDT

TORONTO, ON--(Marketwired - September 26, 2016) - The federal House of Commons Standing Committee on Health has been holding ongoing hearings about the Development of a National Pharmacare Program in Canada. Advocates of national pharmacare have told the Committee that Canada should adopt a New Zealand-style prescription drug system. However, a new study suggests that importing New Zealand-styled pharmacare policies into our country would lead to fewer drug treatment options and poorer health outcomes for Canadian patients.

Diabetes Epidemic Fostering Modest Growth in Global Diabetes Market, Reports BCC Research

Mon, 26 Sep 2016 05:30:00 EDT

WELLESLEY, MA--(Marketwired - September 26, 2016) - The rising prevalence of Type 1 and Type 2 diabetes is keying growth of the global diabetes market. BCC Research reveals in its new report that technology also is driving growth, especially in the market sector for insulin pumps and accessories.

Diet Doc Facilitates Healthy Weight Loss and Reduces Emotional Eating Without Ketogenic Diet

Mon, 26 Sep 2016 01:00:00 EDT

RIVERTON, WY--(Marketwired - September 26, 2016) - Obesity has become an epidemic, two out of three Americans are overweight or obese and struggling to find healthy and reliable weight maintenance solutions. Many individuals struggle with excessive hunger between meals; insatiable cravings for unhealthy food; inability to control eating behavior or speed; and eating continuously throughout the day without any planned mealtimes. Emotional eating due to everyday stress worsens the situation. Nutrition deficiency and lack of physical exercise leads to health issues like heart disease, type 2 diabetes, and hypertension. This makes weight loss an urgent need.

Ogilvy CommonHealth Worldwide's Australian Office Takes Home Four Accolades at the 2016 WPPED Cream Awards

Fri, 23 Sep 2016 11:29:41 EDT

PARSIPPANY, NJ--(Marketwired - Sep 23, 2016) - Ogilvy CommonHealth Worldwide (, the health behavior change specialists of Ogilvy & Mather (, and a WPP company (NASDAQ: WPPGY) (, today announced the Australian office of Ogilvy CommonHealth Worldwide has been honored with four recognitions in the healthcare category of the 10th Annual WPPED Cream Awards, which recognizes the very best work produced by WPP companies around the world, and across all marketing disciplines.

World Renowned Sexologist Dr. Kristina Kincaid Becomes Brand Ambassador for MJTV's New Neuroceutical Female Arousal Booster

Fri, 23 Sep 2016 08:00:00 EDT

WHIPPANY, NJ--(Marketwired - Sep 23, 2016) - Michael James Enterprises, Inc. (OTCQB: MJTV) is pleased to report that Dr. Kristina Kincaid signed a binding letter of intent to become the Brand Ambassador for the female sexual arousal enhancer. The final definitive agreement should be signed in the next week.

Moleculin Biotech to Present at OktoberINVESTfest

Fri, 23 Sep 2016 08:00:00 EDT

NEW YORK, NY and HOUSTON, TX--(Marketwired - September 23, 2016) - Moleculin Biotech, Inc., (NASDAQ: MBRX) ("Moleculin" or the "Company"), today announces its upcoming presentation at the fifth annual OktoberINVESTfest presented by Joseph Gunnar & Co. on September 28, 2016. Walter Klemp, Chairman and Acting CEO will provide an overview of the company and, along with Jonathan P. Foster, Chief Financial Officer and Executive Vice President, will meet with members of the investment community.

Greengro Technologies, Unveils Advantageous 'GreenGro 3-Tier Franchise Model'

Fri, 23 Sep 2016 07:30:00 EDT

ANAHEIM, CA--(Marketwired - Sep 23, 2016) - Greengro Technologies, Inc. (OTC PINK: GRNH), a world-class provider of eco-friendly green technologies, has announced the "Greengro 3-Tier Franchise Model" for businesses in the field of controlled environment agriculture (CEA). The three tiers are: 1) Glass Greenhouse Franchise, 2) Glass Greenhouse Franchise / Cannabis Sector, and 3) Vertical Hydrogarden Stores.

Researchers to Present Data on Immunovaccine's Infectious Disease Pipeline at Three International Conferences

Fri, 23 Sep 2016 07:05:00 EDT

Presentations at RSV16, World Vaccine Congress Europe and IDWeek Conferences Highlight Company's Progress in Using DepoVax(TM)-based Agents to Address Respiratory Syncytial Virus (RSV) and Life-Threatening Malaria

Abeona Therapeutics to Present at Ladenburg Thalmann 2016 Healthcare Conference

Fri, 23 Sep 2016 07:03:00 EDT

Company COO to Present on September 27th at 9:30 am ET